Apigenin inhibits ECM production in transforming growth factor-beta 1 (TGF-β1)-stimulated cardiac fibroblasts by modulating specific signaling pathways, which may have implications for tumor-associated fibrosis [98]. Here, TGFB1 is linked to neoplasm.